CHPT vs PPCB · rev $417.1M vs P/E 0.0, $3.9M cap
ChargePoint Holdings Inc (CHPT) versus Propanc Biopharma, Inc. Common Stock (PPCB) — a side-by-side from cached financials, not a winner call.
ChargePoint Holdings Inc (CHPT) is a specialty retail company listed on NYSE.
Propanc Biopharma, Inc. Common Stock (PPCB) is a biotechnology company listed on NASDAQ.
Latest reported CHPT revenue for 2025-01-31 was $417.1M. Net income was -$277.1M. Revenue was down 17.7% from 2024-01-31 to 2025-01-31. CHPT currently screens at market cap $199.2M.
PPCB does not have a complete income-statement cache yet.
CHPT currently screens at market cap $199.2M. PPCB currently screens at market cap $3.9M and trailing P/E 0.0.
Not investment advice. Open the CHPT and PPCB stock pages for the full models.
Not investment advice.